Nicholas M Anstey Selected Research

Parasitemia

1/2021	Endothelial glycocalyx degradation and disease severity in Plasmodium vivax and Plasmodium knowlesi malaria.
1/2020	Early Endothelial Activation Precedes Glycocalyx Degradation and Microvascular Dysfunction in Experimentally Induced Plasmodium falciparum and Plasmodium vivax Infection.
12/2019	Glycocalyx breakdown is increased in African children with cerebral and uncomplicated falciparum malaria.
1/2019	Antiphosphatidylserine Immunoglobulin M and Immunoglobulin G Antibodies Are Higher in Vivax Than Falciparum Malaria, and Associated With Early Anemia in Both Species.
1/2018	Age-Related Clinical Spectrum of Plasmodium knowlesi Malaria and Predictors of Severity.
1/2018	Artemether-Lumefantrine Versus Chloroquine for the Treatment of Uncomplicated Plasmodium knowlesi Malaria: An Open-Label Randomized Controlled Trial CAN KNOW.
1/2018	Reduced red blood cell deformability in Plasmodium knowlesi malaria.
1/2017	Effects of Aging on Parasite Biomass, Inflammation, Endothelial Activation, Microvascular Dysfunction and Disease Severity in Plasmodium knowlesi and Plasmodium falciparum Malaria.
1/2017	Early Immune Regulatory Changes in a Primary Controlled Human Plasmodium vivax Infection: CD1c+ Myeloid Dendritic Cell Maturation Arrest, Induction of the Kynurenine Pathway, and Regulatory T Cell Activation.
1/2016	Profoundly Reduced CD1c+ Myeloid Dendritic Cell HLA-DR and CD86 Expression and Increased Tumor Necrosis Factor Production in Experimental Human Blood-Stage Malaria Infection.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicholas M Anstey Research Topics

Disease

104	Malaria 10/2022 - 01/2002
53	Falciparum Malaria (Plasmodium falciparum Malaria) 10/2022 - 07/2002
47	Infections 10/2022 - 12/2002
26	Vivax Malaria 01/2022 - 12/2002
19	Parasitemia 01/2021 - 09/2002
16	Hemolysis 10/2022 - 10/2007
13	Cerebral Malaria 10/2021 - 02/2003
13	Sepsis (Septicemia) 04/2018 - 05/2004
8	Anemia 04/2020 - 05/2005
7	Acute Kidney Injury (Acute Renal Failure) 10/2022 - 06/2015
7	Melioidosis 01/2020 - 09/2003
7	Tuberculosis (Tuberculoses) 01/2019 - 07/2008
6	Fever (Fevers) 10/2020 - 09/2002
5	Hyperemia 11/2016 - 11/2008
4	Septic Shock (Toxic Shock Syndrome) 12/2021 - 01/2004
4	Pneumonia (Pneumonitis) 01/2020 - 09/2003
4	Glucosephosphate Dehydrogenase Deficiency 01/2019 - 12/2011
3	Coma (Comas) 10/2021 - 02/2013
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 10/2020 - 12/2005
3	Thrombocytopenia (Thrombopenia) 04/2020 - 01/2015
3	Convalescence 01/2020 - 07/2013
3	Pulmonary Tuberculosis 01/2017 - 01/2013
3	Inflammation (Inflammations) 01/2017 - 01/2015
3	Critical Illness (Critically Ill) 12/2013 - 01/2010
3	Acidosis 03/2010 - 08/2002
2	Acute malaria 01/2020 - 06/2009
2	Hypoxia (Hypoxemia) 03/2019 - 02/2013
2	Bacterial Infections (Bacterial Infection) 01/2018 - 01/2016
2	Disease Progression 01/2017 - 09/2002
2	Vascular Diseases (Vascular Disease) 10/2014 - 02/2011
2	Communicable Diseases (Infectious Diseases) 08/2014 - 02/2010
2	Ischemia 02/2013 - 10/2007

Drug/Important Bio-Agent (IBA)

34	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 01/2002
19	Pharmaceutical PreparationsIBA 01/2022 - 07/2002
19	Chloroquine (Aralen)FDA LinkGeneric 01/2021 - 07/2002
19	Arginine (L-Arginine)FDA Link 01/2019 - 02/2003
18	artemisinin (artemisinine)IBA 01/2021 - 12/2002
17	ArtesunateIBA 01/2021 - 12/2002
15	Hemoglobins (Hemoglobin)IBA 10/2022 - 05/2005
15	Antimalarials (Antimalarial Agents)IBA 01/2020 - 09/2002
12	Nitric Oxide Synthase (NO Synthase)IBA 01/2016 - 11/2002
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2005
11	Primaquine FDA Link 11/2020 - 10/2009
8	CytokinesIBA 02/2021 - 09/2002
8	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 09/2003
8	Lactic Acid (Lactate)FDA LinkGeneric 03/2019 - 10/2007
7	AntibodiesIBA 01/2022 - 09/2002
7	piperaquineIBA 12/2021 - 10/2012
7	artenimol (dihydroartemisinin)IBA 12/2021 - 10/2012
7	Interleukin-10 (Interleukin 10)IBA 01/2019 - 05/2005
6	Immunoglobulin G (IgG)IBA 01/2022 - 09/2002
6	VaccinesIBA 01/2022 - 08/2006
6	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2021 - 04/2010
6	HLA-DR Antigens (HLA-DR)IBA 01/2020 - 08/2015
6	Angiopoietin-2IBA 06/2018 - 11/2008
5	CreatinineIBA 10/2022 - 05/2005
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2008
5	AntigensIBA 01/2018 - 06/2009
5	Histidine (L-Histidine)FDA Link 01/2018 - 01/2012
4	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2022 - 01/2018
4	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 04/2019 - 03/2017
4	Oxygen (Dioxygen)IBA 03/2019 - 02/2013
4	Amino Acids FDA Link 01/2019 - 06/2006
4	Interleukin-6 (Interleukin 6)IBA 01/2017 - 07/2010
4	ArginaseIBA 01/2016 - 04/2014
3	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2017
3	Complement System Proteins (Complement)IBA 11/2019 - 11/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 05/2005
3	EnzymesIBA 06/2017 - 02/2010
3	Vitamin D FDA LinkGeneric 01/2017 - 07/2008
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2015 - 04/2013
2	Plasmodium falciparum erythrocyte membrane protein 1IBA 01/2022 - 05/2016
2	PterinsIBA 10/2021 - 03/2015
2	OsteoprotegerinIBA 01/2020 - 06/2018
2	InterferonsIBA 01/2020 - 01/2011
2	Immunoglobulin M (IgM)IBA 01/2019 - 09/2002
2	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 01/2018 - 01/2017
2	KynurenineIBA 01/2017 - 01/2011
2	Mefloquine (Lariam)FDA LinkGeneric 02/2016 - 01/2016
2	Interleukin-12 (IL 12)IBA 01/2016 - 11/2003
2	Messenger RNA (mRNA)IBA 01/2016 - 08/2014
2	BiopterinsIBA 03/2015 - 03/2015
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 03/2015 - 07/2010
2	Phenylalanine (L-Phenylalanine)FDA Link 03/2015 - 06/2006
2	7,8-dihydrobiopterinIBA 03/2015 - 03/2015
2	sapropterin (tetrahydrobiopterin)FDA Link 03/2015 - 03/2015
2	E-SelectinIBA 01/2015 - 07/2010
2	Quinine (Quinson)FDA Link 01/2014 - 06/2008
2	Essential Amino AcidsIBA 02/2011 - 01/2011
2	Lymphotoxin-alpha (Lymphotoxin)IBA 10/2010 - 07/2010
2	Bicarbonates (Hydrogen Carbonate)IBA 03/2010 - 09/2003
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 02/2010 - 12/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2010 - 11/2008

Therapy/Procedure

33	Therapeutics 01/2021 - 12/2002
8	Aftercare (After-Treatment) 01/2022 - 05/2002
3	Splenectomy 01/2021 - 09/2016
3	Blood Transfusion (Blood Transfusions) 07/2016 - 11/2014
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2017 - 01/2015
2	Length of Stay 12/2015 - 02/2008
2	Resuscitation 01/2015 - 11/2014